The ROADMAP trial: olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.15, 2011-10, pp. : 2421-2424

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The prevention of type 2 diabetes mellitus

By Davies Melanie J.

Clinical Medicine, Vol. 3, Iss. 5, 2003-09 ,pp. : 470-474

Royal College Of Physicians

Access to resources Recommend Favorite

Orlistat: In the Prevention and Treatment of Type 2 Diabetes Mellitus

By Keating G.M. Jarvis B.

Drugs, Vol. 61, Iss. 14, 2001-01 ,pp. : 2107-2119

Adis International

Access to resources Recommend Favorite

Prevention of Type 2 diabetes: fact or fiction?

By Chiasson Jean-Louis

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 18, 2007-12 ,pp. : 3147-3158

Informa Healthcare

Access to resources Recommend Favorite

Time course of antiproteinuric effect of aliskiren in arterial hypertension associated with type 2 diabetes and microalbuminuria

By Fogari Roberto Mugellini Amedeo Zoppi Annalisa Preti Paola Maffioli Pamela Perrone Tiziano Derosa Giuseppe

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 4, 2013-03 ,pp. : 371-384

Informa Healthcare

Access to resources Recommend Favorite

Effect of imidapril versus ramipril on urinary albumin excretion in hypertensive patients with type 2 diabetes and microalbuminuria

By Fogari Roberto Mugellini Amedeo Zoppi Annalisa Gualtierotti Roberta Lazzari Pierangelo Derosa Giuseppe D’Angelo Angela

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 18, 2013-12 ,pp. : 2463-2473

Informa Healthcare

Access to resources Recommend Favorite